Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
11/03/2011 | US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides |
11/03/2011 | US20110268723 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration |
11/03/2011 | US20110268722 Combination therapies with mitochondrial-targeted anti-tumor agents |
11/03/2011 | US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles |
11/03/2011 | US20110268695 Use of hmgb fragments as anti-inflammatory agents |
11/03/2011 | US20110268679 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis |
11/03/2011 | US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/03/2011 | US20110268657 Compositions and methods for the treatment of tumor of hematopoietic origin |
11/03/2011 | US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
11/03/2011 | US20110268655 Anti-alpha v immunoliposome compositions, methods and uses |
11/03/2011 | US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres |
11/03/2011 | CA2803254A1 Slit and roundabount (robo) mediated lymph vessel formation and uses thereof |
11/03/2011 | CA2795799A1 Anti-erbb3 antibodies |
11/03/2011 | CA2795544A1 Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor |
11/02/2011 | EP2383343A2 Recombinant varicella-zoster virus |
11/02/2011 | EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
11/02/2011 | EP2383295A1 IP-10 antibodies and their uses |
11/02/2011 | EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
11/02/2011 | EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
11/02/2011 | EP2383288A2 Differential in tumour gene products and use of same |
11/02/2011 | EP2383285A2 Peptide Sequences and Compositions |
11/02/2011 | EP2383284A2 Peptide sequences and compositions |
11/02/2011 | EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation |
11/02/2011 | EP2382990A1 Methods for treating cancer using an immunotoxin |
11/02/2011 | EP2382989A1 Method for preparing recombinant antigen complex using rotavirus nanoparticle |
11/02/2011 | EP2382988A1 Combined mucosal and parenteral immunization against HIV |
11/02/2011 | EP2382987A1 Storage of influenza vaccines without refrigeration |
11/02/2011 | EP2382986A2 Vaccine against streptococcus pneumoniae |
11/02/2011 | EP2382985A1 Recombinant avian-infectious coryza vaccine and method for producing same |
11/02/2011 | EP2382316A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
11/02/2011 | EP2382314A1 C1orf59 peptides and vaccines including the same |
11/02/2011 | EP2382307A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
11/02/2011 | EP2381960A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
11/02/2011 | EP2381959A1 Stable vaccine compositions and methods of use |
11/02/2011 | EP2381958A1 Potato virus a coat protein-based vaccine for treating melanoma and its use |
11/02/2011 | EP2381949A1 Immunostimulating saponins for use in in situ tumor-destruction therapy |
11/02/2011 | EP2381934A2 Improving cognitive function |
11/02/2011 | EP2381920A2 Methods and compositions for treating p.acnes |
11/02/2011 | EP2381788A2 Targeted cryptosporidium biocides |
11/02/2011 | EP2351581A9 A vaccine composition against foot-and-mouth disease and the preparation method thereof |
11/02/2011 | EP2051710B1 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
11/02/2011 | EP1843787B1 Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
11/02/2011 | EP1836225B1 Kir-binding agents and methods of use thereof |
11/02/2011 | EP1827437B1 Combinations of therapeutic agents for treating cancer |
11/02/2011 | EP1756143B1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
11/02/2011 | EP1755659B1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
11/02/2011 | EP1730194B1 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof |
11/02/2011 | EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
11/02/2011 | EP1572746B1 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
11/02/2011 | EP1508043B1 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
11/02/2011 | EP1501542B2 Improved polysaccharide and glycoconjugate vaccines |
11/02/2011 | EP1425389B1 Human antibodies specific for interleukin 15 (il-15) |
11/02/2011 | EP1386165B1 Inflammatory markers for detection and prevention of diabetes mellitus |
11/02/2011 | EP1311290B1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
11/02/2011 | EP1299522B1 Alteration of cell membrane |
11/02/2011 | EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
11/02/2011 | EP1036180B2 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd) |
11/02/2011 | CN1759121B Purification process for bacterial cytolysin |
11/02/2011 | CN1753912B Antibodies against PD-1 and uses therefor |
11/02/2011 | CN1629185B Fusion proteins of mycobacterium tuberculosis antigens and their uses |
11/02/2011 | CN102232115A Methods and compositions for diagnosing and treating a colorectal adenocarcinoma |
11/02/2011 | CN102232088A Anti-PCSK9 and methods for treating lipid and cholesterol disorders |
11/02/2011 | CN102232086A Process for the modulation of the antagonistic activity of a monoclonal antibody |
11/02/2011 | CN102232083A 禽流感疫苗 Bird flu vaccine |
11/02/2011 | CN102229916A Chicken Flavivirus and inactivated vaccine thereof |
11/02/2011 | CN102229915A EV71 virus monoclonal antibody, hybridoma cell line and application |
11/02/2011 | CN102229671A Anti-IMMT anthropogenic Fab antibody and application thereof in preparing anti-liver cancer drugs |
11/02/2011 | CN102229660A Truncated human papillomavirus 33 type L1 protein |
11/02/2011 | CN102229651A Amyloid protein intra-membrane segment for treating Alzheimer disease and application thereof |
11/02/2011 | CN102229648A HLA-A*0201 restrictive CTL (cytotoxic T lymphocyte) epitope for tumor antigen Pokemon and application thereof |
11/02/2011 | CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
11/02/2011 | CN102228698A HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof |
11/02/2011 | CN102228688A OmpC-HBsAg (Outer membrane protein Complex-Hepatitis B surface Antigen) 'a' chimeric epitope therapeutic vaccine for hepatitis B |
11/02/2011 | CN102228687A Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine |
11/02/2011 | CN102228686A Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell |
11/02/2011 | CN102228685A Preparation method of iridovirus cell inactivated vaccine for Chinese giant salamanders, and application method thereof |
11/02/2011 | CN102228482A Propolis injection for preventing duck hemorrhagic oophoritis and preparation method thereof |
11/02/2011 | CN102228481A Propolis injection for preventing type I duck virus hepatitis and preparation method thereof |
11/02/2011 | CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
11/01/2011 | US8049001 Probe, probe set, probe carrier, and testing method |
11/01/2011 | US8048993 Heparanase specific molecular probes and their use in research and medical applications |
11/01/2011 | US8048985 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
11/01/2011 | US8048918 Treatment of hyperproliferative diseases |
11/01/2011 | US8048858 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
11/01/2011 | US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use |
11/01/2011 | US8048844 Preventing airway mucus production by administration of EGF-R antagonists |
11/01/2011 | US8048434 Mycobacterium W and/or its constituents; nonpathogenic, cultivable |
11/01/2011 | US8048433 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica |
11/01/2011 | US8048432 Polysaccharide-protein conjugate vaccines |
11/01/2011 | US8048431 Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domain |
11/01/2011 | US8048430 Influenza hemagglutinin and neuraminidase variants |
11/01/2011 | US8048429 Inactivated chimeric flavivirus |
11/01/2011 | US8048428 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof |
11/01/2011 | US8048427 Subgenomic replicons of the flavivirus dengue |
11/01/2011 | US8048425 modified to be cytotoxic by altering its amino acid sequence so that it is not bound easily by the ribonuclease inhibitor while still retaining catalytic properties |
11/01/2011 | US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same |
11/01/2011 | US8048423 Treating warts, corns, bunions, ulcers, calluses, neuromas, ulcers, and hammertoes; reducing pain, size of the skin disorder, or inflammation |
11/01/2011 | US8048422 Tweak binding antibodies |
11/01/2011 | US8048421 Agonist antibody to human thrombopoietin receptor |
11/01/2011 | US8048420 Monoclonal antibody |